FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 63 filers reported holding FOGHORN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,006,555 | -29.3% | 201,311 | -0.4% | 0.00% | – |
| Q2 2023 | $1,423,242 | +23.4% | 202,165 | +8.6% | 0.00% | – |
| Q1 2023 | $1,153,665 | -0.3% | 186,075 | +2.6% | 0.00% | – |
| Q4 2022 | $1,157,415 | -26.7% | 181,413 | -1.5% | 0.00% | – |
| Q3 2022 | $1,580,000 | -37.9% | 184,149 | -1.5% | 0.00% | -100.0% |
| Q2 2022 | $2,543,000 | -0.9% | 186,998 | +11.0% | 0.00% | – |
| Q1 2022 | $2,566,000 | -34.2% | 168,462 | -1.2% | 0.00% | -100.0% |
| Q4 2021 | $3,899,000 | +59.9% | 170,476 | -2.6% | 0.00% | – |
| Q3 2021 | $2,439,000 | +40.3% | 175,072 | +7.5% | 0.00% | – |
| Q2 2021 | $1,738,000 | +56.6% | 162,900 | +93.2% | 0.00% | – |
| Q1 2021 | $1,110,000 | -38.1% | 84,296 | -4.7% | 0.00% | – |
| Q4 2020 | $1,792,000 | – | 88,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $25,566,000 | 5.41% |
| Flagship Pioneering Inc. | 12,674,120 | $256,905,000 | 4.68% |
| Birchview Capital, LP | 314,143 | $6,368,000 | 3.67% |
| Monashee Investment Management LLC | 560,360 | $11,359,000 | 1.50% |
| Artal Group S.A. | 1,720,720 | $34,879,000 | 0.75% |
| Alphabet Inc. | 500,901 | $10,153,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,270,000 | 0.48% |
| Casdin Capital, LLC | 216,216 | $4,383,000 | 0.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 258,700 | $5,244,000 | 0.08% |
| Woodline Partners LP | 103,040 | $2,089,000 | 0.06% |